Stuart Rich
Chief Tech/Sci/R&D Officer bij TENAX THERAPEUTICS, INC.
Vermogen: 12 173 $ op 29-02-2024
Profiel
Stuart Rich founded PHPrecisionMed, Inc. Dr. Rich is Chief Medical Officer & Director at Tenax Therapeutics, Inc. He is also Professor-Medicine at Northwestern University and Director-Pulmonary Vascular Disease Program at Bluhm Cardiovascular Institute.
In his past career Dr. Rich held the position of Chief Medical Officer of United Therapeutics Corp., Chief Executive Officer & Director at PHPrecisionMed, Inc., Professor at the University of Illinois College of Medicine, Professor-Medicine at Rush Medical College and Professor at Pritzker School of Medicine.
Dr. Rich received an undergraduate degree from the University of Illinois and a doctorate from Stritch School of Medicine.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
TENAX THERAPEUTICS, INC.
0.15% | 16-10-2023 | 2 652 ( 0.15% ) | 12 173 $ | 29-02-2024 |
Actieve functies van Stuart Rich
Bedrijven | Functie | Begin |
---|---|---|
TENAX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 15-01-2021 |
Bluhm Cardiovascular Institute
Bluhm Cardiovascular Institute Medical/Nursing ServicesHealth Services Bluhm Cardiovascular Institute operates a hospital specializing in cardiology. The private company is based in Chicago. | Corporate Officer/Principal | 01-07-2015 |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | Corporate Officer/Principal | 01-07-2015 |
Eerdere bekende functies van Stuart Rich
Bedrijven | Functie | Einde |
---|---|---|
PHPrecisionMed, Inc.
PHPrecisionMed, Inc. Pharmaceuticals: MajorHealth Technology Part of Tenax Therapeutics, Inc., PHPrecisionMed, Inc. develops medical drugs. The American company was founded by Stuart Rich. PHPrecisionMed was acquired by Tenax Therapeutics, Inc. on January 19, 2021 for $3.37 million. | Founder | 01-01-2021 |
Pritzker School of Medicine | Corporate Officer/Principal | 01-07-2015 |
UNITED THERAPEUTICS CORPORATION | Chief Tech/Sci/R&D Officer | 01-12-2004 |
Rush Medical College | Corporate Officer/Principal | 01-09-2004 |
University of Illinois College of Medicine | Corporate Officer/Principal | 01-07-1996 |
Opleiding van Stuart Rich
University of Illinois | Undergraduate Degree |
Stritch School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
TENAX THERAPEUTICS, INC. | Health Technology |
UNITED THERAPEUTICS CORPORATION | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Bluhm Cardiovascular Institute
Bluhm Cardiovascular Institute Medical/Nursing ServicesHealth Services Bluhm Cardiovascular Institute operates a hospital specializing in cardiology. The private company is based in Chicago. | Health Services |
PHPrecisionMed, Inc.
PHPrecisionMed, Inc. Pharmaceuticals: MajorHealth Technology Part of Tenax Therapeutics, Inc., PHPrecisionMed, Inc. develops medical drugs. The American company was founded by Stuart Rich. PHPrecisionMed was acquired by Tenax Therapeutics, Inc. on January 19, 2021 for $3.37 million. | Health Technology |